Créer un compte gratuit
Rejoignez Calaméo pour publier et partager vos documents !
Notez et commentez vos publications favorites, téléchargez des documents, partagez vos lectures avec vos amis.
Access Pharma Offers Medicines With Big Potential For Low Valuation
2 pages
Publié par
saravanan2
Copyright :
Tous droits réservés
BiomedReports, the news portal covering the biomedical news and financial sector is
profiling Access Pharma (OTC:ACCP) in a special report today.
Los Angeles, CA, May 08, 2009 -- BiomedReports, the news portal covering the
biomedical...
[Plus]
BiomedReports, the news portal covering the biomedical news and financial sector is
profiling Access Pharma (OTC:ACCP) in a special report today.
Los Angeles, CA, May 08, 2009 -- BiomedReports, the news portal covering the
biomedical news and financial sector is profiling Access Pharma (OTC:ACCP) in a
special report today.
With shares of Cell Therapeutics (NASDAQ:CTIC) staging an astonishing comeback
rising from $.
08 cents a share at the time of BiomedReport s original article in
early February to as high as $1.
85 during intraday trading yesterday, biomedical
reporter Mike Havrilla went in search of another out-of-favor name in the cancer
biotech space.
what he found was Access Pharma (OTC:ACCP), an emerging bio-pharma company which is
focusing on the development of a late-stage, diversified oncology pipeline in
addition to an FDA approved treatment for a side effect of some cancer treatments
known as mucositis (painful sores in the mouth and GI mucosal lining).
Valued at roughly
[Moins]
Tags
access,
accp,
biomedical,
biomedreports,
company,
covering,
date,
forward,
havrilla,
news,
pharma,
report,
sector,
special,
statements,
stock,
today
